Apollo Cancer Centres launches breast cancer detection test in tie up with Datar Cancer Genetics

The EasyCheck- Breast test developed by Nashik-based molecular diagnostics company Datar Cancer Genetics, has received breakthrough designated status by USFDA and has been approved by the UK and Europe. The test is designed to detect breast adenocarcinoma specific cancer tumor cells in the blood.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/NBhG0LC
via IFTTT